Entinostat in combination with nivolumab for patients with advanced cholangiocarcinoma: a phase 2 clinical trial.
- Published in:
- Epigenetics Communications, 2025, v. 5, n. 1, p. 1, doi. 10.1186/s43682-025-00037-z
- By:
- Publication type:
- Article
Works in Epigenetics Communications, 2025, Vol 5, Issue 1
Results: 6
1
2
Polyphenols reverse ROS induced epigenetic alterations in the process of carcinogenesis.
- Published in:
- Epigenetics Communications, 2025, v. 5, n. 1, p. 1, doi. 10.1186/s43682-025-00034-2
- By:
- Publication type:
- Article
3
Meeting report on the round table discussions ‘epigenetics and society’ CLEPIC24.
- Published in:
- Epigenetics Communications, 2025, v. 5, n. 1, p. 1, doi. 10.1186/s43682-025-00035-1
- By:
- Publication type:
- Article
4
Thorn within: the environment in personal identity.
- Published in:
- Epigenetics Communications, 2025, v. 5, n. 1, p. 1, doi. 10.1186/s43682-025-00036-0
- By:
- Publication type:
- Article
5
qBiCo: a method to assess global DNA conversion performance in epigenetics via single-copy genes and repetitive elements.
- Published in:
- Epigenetics Communications, 2025, v. 5, n. 1, p. 1, doi. 10.1186/s43682-025-00033-3
- By:
- Publication type:
- Article
6
Uncovering the significance of CBX3 as an up-and-coming biomarker in cardio-vascular health.
- Published in:
- Epigenetics Communications, 2025, v. 5, n. 1, p. 1, doi. 10.1186/s43682-024-00032-w
- By:
- Publication type:
- Article